AI in Breast Cancer Risk Prediction: Clairity to Showcase New Research at RSNA 2025
Clairity
Clairity’s first FDA authorized AI platform for breast cancer prediction demonstrates consistent accuracy, real-world impact, and potential to transform global breast cancer screening

